| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |